I think luckin coffee is better thanStarbucks. Thing is l don't drink thosefancy fraps and only go for Americano orLattes. So just on straight coffee, theyare better.l can't speak for the fancystuff though.
I have found gold to be a good counterweight to equities lately. Seems like when stocks fall, gold rises lately.It's a terrible investment most of the time but over a very long term, like 100 years, it's actually a very important asset to own at times. $Ninety One GSF Global Gold Fund(LU1858852160.MF$
7
嗯,我得说我对科技基金还是很有信心的,毕竟科技行业一直都是这个市场的主角,而且未来也不会改变。虽然最近科技股有些波动,但我认为这只是个暂时的调整。不过,基金投资永远都是有风险的
1
Because there is a trend of an aging population and the demand for medicine is immediate and not affected by macroeconomics.
In this case, the growth potential of the medical industry and the competitive landscape of the industry are relatively stable; the current valuation is relatively reasonable and can traverse the cycle! $AB International Health Care Portfolio Fund(LU0058720904.MF$
In this case, the growth potential of the medical industry and the competitive landscape of the industry are relatively stable; the current valuation is relatively reasonable and can traverse the cycle! $AB International Health Care Portfolio Fund(LU0058720904.MF$
1
Each individual has a different personality, investment style preferences, current and future capital needs, etc. All of these factors affect each individual's risk and expected return on investment. As investments are viewed as a whole portfolio, different portfolios including but not limited to securities, bonds, funds, commodities and derivatives are used to seek higher returns with lower risk (generally speaking, margin trading is a separate issue). The r...
1
I want to buy this fund because I want to expand my income sources, Singapore dividend benefits have always been solid, and this fund still has a good long-term trend to try.
2
$ChemoCentryx(CCXI.US$ ChemoCentryx (NASDAQ:CCXI) also drew massive buying interest. Shares nearly doubled after the U.S. Food and Drug Administration approved its TAVNEOS drug.
$人人网(RENN.US$ Outside the energy space, Renren (NYSE:RENN) was another noteworthy winner on the session. Shares jumped nearly 50% on news of a $300M settlement in a shareholder lawsuit brought against the company's founders.
4